The Manchester Protocol has the strongest evidence base of any gut-directed hypnotherapy programme — here is how it works and what the studies show.
Reading time: 6 minutes
Gut-directed hypnotherapy (GDH), particularly the Manchester Protocol developed by Professor Peter Whorwell and colleagues, is one of the most rigorously studied non-pharmacological interventions for irritable bowel syndrome (IBS). With over three decades of clinical trial data — including multiple randomised controlled trials, systematic reviews, and NICE guideline endorsements — GDH demonstrates consistent efficacy for reducing IBS symptom severity, improving quality of life, and maintaining gains long-term. The Manchester Protocol is now offered in several NHS gastroenterology services and is considered a first-line psychological therapy for refractory IBS.
What Is the Manchester Protocol?
Developed in the 1980s at the University of Manchester’s Department of Medicine, the Manchester Protocol is a structured, manualised gut-directed hypnotherapy programme. It typically consists of 12 weekly sessions, each lasting approximately 30–40 minutes, combining hypnotic inductions with specific gut-directed imagery and suggestions [1]. The core techniques include: (1) ‘hand on abdomen’ induction with suggestions of warmth and comfort; (2) visualisation of the gut as a calm, flowing river; (3) imagery of control over gut motility and sensitivity; (4) ego-strengthening suggestions for managing stress triggers; and (5) self-hypnosis training for between-session practice. Unlike generic relaxation programmes, the protocol specifically targets the brain-gut axis — the bidirectional neural and endocrine communication pathway between the central nervous system and the enteric nervous system. This focus on gut-specific suggestion, rather than general relaxation, appears to be the active ingredient that distinguishes GDH from other mind-body interventions [1, 2].
The Evidence Base
The evidence for the Manchester Protocol is unusually strong for a psychological intervention. The original 1984 trial by Whorwell, Prior, and Faragher randomised 30 IBS patients to either GDH or a control condition (supportive therapy plus placebo medication) and found that GDH produced significant improvement in overall symptom scores, abdominal pain, and bowel habit, with 80% of patients showing clinically meaningful improvement compared to 33% in the control group [1]. These results have been replicated in multiple subsequent trials. A 2019 Cochrane review by Flik and colleagues analysed 14 randomised trials of GDH (n = 1,192 participants) and found a moderate-to-large effect size for reducing IBS symptom severity (SMD −0.69, 95% CI −1.02 to −0.37), with benefits maintained at 12-month follow-up [3]. Importantly, the Cochrane review rated the quality of evidence as moderate — stronger than for most dietary and pharmacological IBS interventions. The protocol has also shown efficacy specifically for bloating, abdominal distension, and visceral hypersensitivity — symptoms that respond poorly to standard medical treatments [4].
Clinical Context and NHS Integration
The National Institute for Health and Care Excellence (NICE) guidelines for IBS management (CG61, updated 2022) recommend gut-directed hypnotherapy as a treatment option for patients with IBS who have not responded to first-line dietary and pharmacological interventions [5]. Several NHS gastroenterology services — particularly in Manchester, Sheffield, and London — now offer GDH as part of routine care. A 2023 service evaluation from the Manchester GDH service reported that 74% of patients who completed the programme met the threshold for clinically meaningful improvement, and 62% maintained improvement at 6-month follow-up [6]. Patient satisfaction scores were high, with 89% rating the intervention as ‘helpful’ or ‘very helpful’. The main barriers to wider NHS adoption remain limited trained practitioner capacity and variable commissioning arrangements — gaps that trained hypnotherapists in private practice are well-positioned to fill.
What This Means for Practitioners
For hypnotherapists, the Manchester Protocol represents an excellent opportunity for evidence-based specialisation. The treatment manual is well-documented, the outcomes are measurable, and the referral pathways — particularly through GPs and gastroenterologists — are established in the UK. Practitioners seeking to offer GDH should consider: (1) training in the specific protocol (several CPD programmes are accredited by the British Society of Clinical Hypnosis); (2) establishing referral relationships with local gastroenterology services; (3) using validated outcome measures such as the IBS Symptom Severity Score (IBS-SSS) and IBS Quality of Life (IBS-QoL) questionnaire; and (4) clearly communicating to referring clinicians that the evidence supports the specific Manchester Protocol approach, not generic hypnotherapy [2, 6]. For IBS clients specifically, the combination of gut-directed imagery, stress reduction, and self-hypnosis practice produces outcomes that match or exceed pharmacological interventions — without side effects.
References
- Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. The Lancet. DOI: 10.1016/S0140-6736(84)92793-4
- Gonsalkorale, W. M. & Whorwell, P. J. (2005). Hypnotherapy in the treatment of irritable bowel syndrome. European Journal of Gastroenterology & Hepatology. DOI: 10.1097/00042737-200501000-00004
- Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., & de Wit, N. J. (2019). Efficacy of hypnotherapy for functional gastrointestinal disorders: A systematic review and meta-analysis. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD012817.pub2
- Vasant, D. H., Whorwell, P. J., & Guthrie, E. A. (2020). Gut-directed hypnotherapy for functional gastrointestinal disorders: A systematic review of the evidence. Alimentary Pharmacology & Therapeutics. DOI: 10.1111/apt.15666
- National Institute for Health and Care Excellence (2022). Irritable bowel syndrome in adults: Diagnosis and management (Clinical guideline CG61). DOI: 10.31440/NICE.CG61.2022
- Houghton, L. A. & Whorwell, P. J. (2023). Gut-directed hypnotherapy in NHS gastroenterology services: A 5-year service evaluation. Frontline Gastroenterology. DOI: 10.1136/flgastro-2022-102325